Our portfolio
We’re proud to have backed more than 600 growing businesses and supported standout exits across the UK and Ireland. Explore our portfolio, past and present, below.
OrganOx
Life Sciences
South East
Early Stage
2020 - 2025
Exited
Abselion
Life Sciences
South East
Early Stage
2021
Current
Caristo Diagnostics
Life Sciences
South East
Early Stage
2020
Current
Cellular Origins
Life Sciences
East of England
Early Stage
2025
Current
Closed Loop
Life Sciences
London
Early Stage
2020
Current
Cyted
Life Sciences
East of England
Early Stage
2023
Current
Enhanced Genomics
Life Sciences
East of England
Early Stage
2022
Current
Entia
Life Sciences
London
Early Stage
2021
Current
IQ Endoscopes
Life Sciences
Wales
Early Stage
2023
Current
Locate Bio
Life Sciences
Midlands
Early Stage
2021
Current
Maxion Therapeutics
Life Sciences
East of England
Early Stage
2023
Current
MOA
Life Sciences
South East
Early Stage
2022
Current
NanoSyrinx
Life Sciences
East of England
Early Stage
2024
Current
Oxford Brain Diagnostics
Life Sciences
East of England
Early Stage
2023
Current
Pathfinder Medical
Life Sciences
East of England
Early Stage
2022
Current
T-Therapeutics
Life Sciences
East of England
Early Stage
2025
Current
TidalSense
Life Sciences
East of England
Early Stage
2020
Current
Tozaro
Life Sciences
East of England
Early Stage
2020
Current
ViaNautis Bio
Life Sciences
East of England
Early Stage
2023
Current
Wobble Genomics
Life Sciences
Scotland
Early Stage
2024
Current
1